Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants

Published:2023-01 Issue: Volume:Volume 17 Page:209-218
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Cheung Tommy Tsang,Mai Tu H,Chia Yen Lin,Yap Desmond YH,Lee Chi-Ho,Chen Cecil Chi-Keung,Huang Ying,Jin Yuwen,Johnston James,Werkström Viktoria,Yao Yuhui,Ge Xiaoyun,Zheng Wenying

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference15 articles.

1. Eosinophilic and Noneosinophilic Asthma

2. Biological therapy for severe asthma

3. Biologic therapy in the management of asthma

4. Biological therapies for eosinophilic asthma

5. MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 1, randomized, double-blind, placebo-controlled, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of SHR-1905, a long-acting anti-thymic stromal lymphopoietin antibody, in healthy subjects;Frontiers in Pharmacology;2024-07-15

2. Insight into IL-5 as a Potential Target for the Treatment of Allergic Diseases;Biomedicines;2024-07-10

3. Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety (TATE study);Pediatric Allergy and Immunology;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP